Since metastatic relapse is a major reason of cancer-related deaths, we asked whether we could stratify colon cancer patients based on Fra-1 expression levels, similar to what we have shown recently for breast cancer [7]. This evidence concerns the gene FOSL1 and malignant colon neoplasm.